Anzeige
Mehr »
Donnerstag, 15.05.2025 - Börsentäglich über 12.000 News
Verpasst du gerade die Buffett-Aktie der neuen Generation?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
17.04.GSK kicks off Blenrep's market return with first myeloma combo nod in UK
17.04.TV drug ad spending continues upward climb, logging nearly 30% growth in Q1
17.04.AstraZeneca's Alexion accused of extending Soliris monopoly through sham patents in new suit
17.04.RSV shots from GSK, Pfizer get potential boost from broadened ACIP guidance
17.04.Moderna advances pandemic preparedness agenda with UK clearance for commercial mRNA vaccine plant
17.04.Ipsen's liver disease drug Iqirvo off to promising launch in battle with Gilead's Livdelzi
16.04.RFK Jr. targets HHS' vaccine safety reporting system, pledges changes: Stat
16.04.CDC vaccine panel review indicates potential changes to COVID, HPV immunization policies
16.04.GSK scolded after complainant flags 'shocking error' in prescribing information
16.04.Trump throws pharma 'bread crumb' concession with call to end IRA pill penalty
16.04.With looming Trump tariffs, pharma companies demand changes to stay in EU
16.04.Bluebird, after exploring 2nd buyout offer, sticks with Carlyle and SK Capital deal
15.04.Apellis, AstraZeneca break down their FierceMadness 2025 Drug Ad Tournament success
15.04.As Johnson & Johnson navigates changing tariff landscape, execs lay out their expectations
15.04.BMS' growth driver Camzyos fails in heart disease trial, denting expansion opportunity
15.04.After delay, first CDC vaccine panel under RFK Jr. meets to hash out recommendations
15.04.Sanofi signs up Chrissy Teigen for diabetes screening campaign
15.04.Trump administration launches national security investigation into pharmaceuticals, paving way for tariffs
14.04.Amgen bumps up pay for longtime CEO Robert Bradway 8% to $24.4M
14.04.Aurobindo gets Form 483 scolding from FDA at North Carolina inhaler plant
14.04.RFK Jr. blasts FDA as industry's 'sock puppet,' warns about 'deep state' influence at agency: Politico
14.04.Sandoz takes Amgen to court again, challenging its patents on decades-old Enbrel
14.04.In short reprieve for pharma, commerce secretary says drug tariffs to come 'in the next month or two'
14.04.'Saturday Night Live' skewers drug ad tropes in Jon Hamm-led skit
14.04.Gilead reprimanded after PMCPA finds conference Wi-Fi sponsorship broke advertising rules